Related Experiment Video
Updated: Mar 10, 2026

09:11
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
10.7K
A Proposed Standardized Scoring Equation for Murine Models of Colitis
Lauren Mayer1, Maddy Frech2, Nneze Ekowa2
1Integrated Biomedical Sciences, University of Notre Dame, Notre Dame, IN, USA. Lmayer2@nd.edu.
Digestive Diseases and Sciences
|March 8, 2026
Summary
This study introduces a simplified scoring system for colitis severity in mouse models of inflammatory bowel disease (IBD). The Boone-Mayer Scoring System aims to standardize assessments in pre-clinical IBD research.
Area of Science:
- Pre-clinical research
- Inflammatory Bowel Disease (IBD) modeling
- Murine models of colitis
Background:
- Histological scoring of colitis is crucial for grading severity in pre-clinical inflammatory bowel disease (IBD) mouse models.
- Lack of a standardized scoring system hinders consistent research across laboratories.
- Currently, over 30 different scoring systems exist within the IBD research community.
Purpose of the Study:
- To propose a simplified, standardized scoring equation for colitis severity in pre-clinical IBD research.
- To streamline and advance research on pre-clinical models of colitis.
- To establish a consistent method for evaluating colitis severity in murine models.
Main Methods:
- Utilized multiple linear regression analysis.
- Identified 4 significant canonical characteristics of colitis out of 8.
- Developed a simplified model equation with a high goodness-of-fit (R² = 0.908).
Main Results:
- The developed scoring model demonstrated strong performance in both non-ulcerative and ulcerative mouse models of colitis.
- The model effectively assesses colitis severity.
- Achieved a high coefficient of determination (R² = 0.908) indicating a good fit.
Conclusions:
- The Boone-Mayer Scoring System is proposed as a standardized method for assessing colitis severity in murine models of IBD.
- This system aims to improve consistency and comparability of results across pre-clinical IBD research laboratories.
- A website with further details is available: https://sites.nd.edu/lauren-mayer/

